Kingsview Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Kingsview Wealth Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-206,252	Closed	-$5.98M	–	1340
2025 Q4	$5.98M	Buy	+206,252	New	+$6.19M	0.09%	248
2021 Q4	–	Sell	-3,946	Closed	-$295K	–	956
2021 Q3	$295K	Sell	3,946 -589	-13%	-$49.4K	0.01%	688
2021 Q2	$421K	Sell	4,535 -7,209	-61%	-$613K	0.02%	607
2021 Q1	$1.05M	Buy	+11,744	New	+$1.16M	0.06%	320

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Kingsview Wealth Management's ARKG Position: Q1 2026 in Review

Kingsview Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2026, closing a stake of 206,252 shares — an estimated $5.98M sold.

Kingsview Wealth Management first reported a position in ARKG in Q1 2021 and held it in 4 quarters. The position peaked at $5.98M in Q4 2025. 220 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

Kingsview Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q1 2026 after selling out during the quarter.
Kingsview Wealth Management sold 206,252 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $5.98M.
Kingsview Wealth Management first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 4 quarters.
Kingsview Wealth Management's ARK Genomic Revolution ETF position peaked at $5.98M in Q4 2025.
220 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Kingsview Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.